Astana Biomed Group, an authorized Abcam distributor in Central Asia

Anti-Integrin beta 7 antibody [FIB504] - BSA and Azide free (ab255954)

Key features and details

  • Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
  • Rat monoclonal [FIB504] to Integrin beta 7 - BSA and Azide free
  • Suitable for: Flow Cyt
  • Reacts with: Mouse, Human

Overview

  • Product name

    Anti-Integrin beta 7 antibody [FIB504] - BSA and Azide free
    See all Integrin beta 7 primary antibodies

  • Description

    Rat monoclonal [FIB504] to Integrin beta 7 - BSA and Azide free

  • Host species

    Rat

  • Tested Applications & Species

    Application Species
    Flow Cyt
    Mouse
    Human
    See all applications and species data

  • Immunogen

    Tissue, cells or virus within Mouse Integrin beta 7. The exact immunogen sequence used to generate this antibody is proprietary information. If additional detail on the immunogen is needed to determine the suitability of the antibody for your needs, please contact our Scientific Support team to discuss your requirements.

    Run BLAST with BLAST the sequence with ExPASy Run BLAST with BLAST the sequence with NCBI

  • Positive control

    • Flow Cyt: Mouse splenocytes. Human PBMCs.

  • General notes

    This antibody clone is manufactured by Abcam. If you require a custom buffer formulation or conjugation for your experiments, please contact orders@abcam.com.

    ab255954 is the carrier-free version of ab254538. This format is designed for use in antibody labeling, including fluorochromes, metal isotopes, oligonucleotides, enzymes.

     

    Our carrier-free formats are supplied in a buffer free of BSA, sodium azide and glycerol for higher conjugation efficiency.

    Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with

    This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm.

    Maxpar® is a trademark of Fluidigm Canada Inc.

    This product is a recombinant monoclonal antibody, which offers several advantages including:

    • - High batch-to-batch consistency and reproducibility
    • - Improved sensitivity and specificity
    • - Long-term security of supply
    • - Animal-free production
    For more information see here.

Properties

Images

  • Flow Cytometry - Anti-Integrin beta 7 antibody [FIB504] - BSA and Azide free (ab255954)
    Flow Cytometry - Anti-Integrin beta 7 antibody [FIB504] - BSA and Azide free (ab255954)

    Flow cytometric analysis of human peripheral blood mononuclear cells labeling Integrin beta 7 with ab254538 at 1.003 µg/mL (red) compared with a Rat IgG, monoclonal Isotype Control (black) and an unlabeled control (cells without incubation with primary antibody and secondary antibody) (blue). Goat anti rat IgG (Alexa Fluor® 488, ab150157) at 1/2000 dilution was used as the secondary antibody.

    Gated on viable cells.

    This image was produced using the same antibody clone but in a different formulation ab254538, PBS, sodium azide, glycerol and BSA.

  • Flow Cytometry - Anti-Integrin beta 7 antibody [FIB504] - BSA and Azide free (ab255954)
    Flow Cytometry - Anti-Integrin beta 7 antibody [FIB504] - BSA and Azide free (ab255954)

    Flow Cytometry analysis of mouse splenocytes labeling Integrin beta 7 with rat IgG isotype control (Left panel) or ab254538 (Right panel, 1.003 µg/mL). The secondary used is Goat anti rat IgG (Alexa Fluor® 488, ab150157) at a 1/2000 dilution. Cells were then stained with anti-CD3 conjugated to Alexa Fluor® 647.
    Gated on viable T cells.

    This image was produced using the same antibody clone but in a different formulation ab254538, PBS, sodium azide, glycerol and BSA.

  • Anti-Integrin beta 7 antibody [FIB504] - BSA and Azide free (ab255954)
    Anti-Integrin beta 7 antibody [FIB504] - BSA and Azide free (ab255954)

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

© 2021 Astana Biomed Group LLP. All rights reserved.